Perspective Therapeutics, Inc. (CATX)
1.15
-0.02
(-1.71%)
USD |
NYAM |
Oct 30, 16:00
1.135
-0.02
(-1.30%)
Pre-Market: 20:00
Perspective Therapeutics 30-Day Average Daily Volume : 2.639M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.639M |
| October 29, 2026 | 2.950M |
| October 28, 2026 | 2.915M |
| October 27, 2026 | 2.815M |
| October 26, 2026 | 2.572M |
| October 23, 2026 | 2.319M |
| October 22, 2026 | 2.199M |
| October 21, 2026 | 2.220M |
| October 20, 2026 | 2.229M |
| October 19, 2026 | 2.204M |
| October 16, 2026 | 2.211M |
| October 15, 2026 | 2.186M |
| October 14, 2026 | 2.176M |
| October 13, 2026 | 2.153M |
| October 12, 2026 | 2.139M |
| October 09, 2026 | 2.148M |
| October 08, 2026 | 2.138M |
| October 07, 2026 | 2.056M |
| October 06, 2026 | 2.039M |
| October 05, 2026 | 1.972M |
| October 02, 2026 | 1.891M |
| October 01, 2026 | 1.843M |
| September 30, 2026 | 1.850M |
| September 29, 2026 | 1.820M |
| September 28, 2026 | 1.807M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.790M |
| September 24, 2026 | 1.774M |
| September 23, 2026 | 1.757M |
| September 22, 2026 | 1.712M |
| September 21, 2026 | 1.571M |
| September 18, 2026 | 1.535M |
| September 17, 2026 | 1.164M |
| September 16, 2026 | 1.182M |
| September 15, 2026 | 1.206M |
| September 14, 2026 | 1.186M |
| September 11, 2026 | 1.146M |
| September 10, 2026 | 1.099M |
| September 09, 2026 | 1.081M |
| September 08, 2026 | 1.064M |
| September 04, 2026 | 1.056M |
| September 03, 2026 | 1.033M |
| September 02, 2026 | 1.021M |
| September 01, 2026 | 1.031M |
| August 31, 2026 | 1.036M |
| August 28, 2026 | 1.037M |
| August 27, 2026 | 1.040M |
| August 26, 2026 | 1.062M |
| August 25, 2026 | 1.085M |
| August 24, 2026 | 1.153M |
| August 21, 2026 | 1.259M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Anika Therapeutics, Inc. | 102338.5 |
| MiMedx Group, Inc. | 1.418M |
| ABVC BioPharma, Inc. | 71583.77 |
| Enovis Corp. | 1.478M |
| Edwards Lifesciences Corp. | 3.603M |